Skip to main content
. 2022 Oct 26;66:204–207. doi: 10.1016/j.breast.2022.10.013

Fig. 2.

Fig. 2

Trend of inclusion of pre-menopausal breast cancer patients in phase III clinical trials over time. Year represents the year of clinical trial opening. Abbreviations: pre-menopausal breast cancer (PMBC), hormone-receptor-positive and HER2-negative breast cancer subtype (HR+/HER2-), endocrine therapy (ET).